Market Risers: Associated British Foods, AstraZeneca, Avacta Group, Bunzl

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Stock in Associated British Foods with EPIC code: LON:ABF has gained 1.15% or 19 points throughout today’s trading session so far. Investors have remained positive while the stock has been in play. Range high for the period so far is 1675 dropping as low as 1630.8. The total volume traded so far comes to 225,269 with the average number of shares traded daily being 1,352,266. A 52 week high for the stock is 2730 equating to 1080 points difference from the previous close and the 52 week low at 1554 which is a variance of 96 points. Associated British Foods now has a 20 moving average of 1829.77 and now the 50 day moving average now at 1860.35. The market capitalisation currently stands at £13,213.04m at the time of this report. The stock is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Associated British Foods being recorded at Thursday, May 21, 2020 at 12:20:15 PM GMT with the stock price trading at 1669 GBX.

Shares in AstraZeneca with company EPIC: LON:AZN has moved up 1.13% or 100 points during today’s session so far. Market buyers seem confident throughout the trading session. The period high was 8982 meanwhile the session low reached 8749. The total volume of shares traded by this point was 491,362 while the daily average number of shares exchanged is 2,401,775. A 52 week share price high is 9056 equating to 174 points different to the previous business close and a 52 week low sitting at 5739 making a difference of 3143 points. AstraZeneca now has a 20 moving average of 8642.33 with a 50 day moving average now at 7830.56. This puts the market cap at £117,865.57m at the time of this report. All share prices mentioned for this stock are traded in GBX. Mcap is measured in GBP. This article was written with the last trade for AstraZeneca being recorded at Thursday, May 21, 2020 at 12:22:16 PM GMT with the stock price trading at 8982 GBX.

Shares of Avacta Group found using EPIC: LON:AVCT has risen 6.8% or 10 points during the course of today’s session so far. Investors seem confident during the trading session. Range high for the period so far is 158.7 dropping as low as 144. The total volume of shares exchanged so far has reached 1,575,843 while the daily average number of shares exchanged is 10,247,929. The 52 week high for the share price is 162 some 15 points difference from the previous days close and putting the 52 week low at 13 which is a variance of 134 points. Avacta Group now has a 20 simple moving average of 120.97 and a 50 day MA at 70.06. The current market cap is £327.36m at the time of this report. The share price is in GBX. Mcap is measured in GBP. This article was written with the last trade for Avacta Group being recorded at Thursday, May 21, 2020 at 12:21:24 PM GMT with the stock price trading at 157 GBX.

Stock in Bunzl with EPIC code: LON:BNZL has gained 2.62% or 46.3 points in today’s trading session so far. Traders have stayed positive throughout the session. The high for the period has peaked at 1819 dipping to 1779.24. The total volume of shares exchanged so far has reached 101,938 while the daily average number of shares exchanged is 1,101,798. A 52 week high for the stock is 2199 around 429.8 points difference from the previous days close and putting the 52 week low at 1242 is a variance of 527.2 points. Bunzl has a 20 SMA of 1758.4 and now its 50 day moving average now at 1664.39. The market cap now stands at £6,112.89m at the time of this report. The currency for this stock is Great British pence.Market cap is measured in GBP. This article was written with the last trade for Bunzl being recorded at Thursday, May 21, 2020 at 12:21:53 PM GMT with the stock price trading at 1815.5 GBX.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
AstraZeneca Plc commits $3.5 billion to boost US research and manufacturing by 2026, creating jobs and expanding its innovation footprint.
AstraZeneca and Amgen's Tezspire shows promise in reducing nasal polyp size and congestion, offering hope for chronic rhinosinusitis patients.
Associated British Foods plc reports strong financial results for the year ending 14 September 2024, showcasing impressive profitability and growth in various sectors.
AstraZeneca's Wainzua gains CHMP backing for EU approval in treating ATTRv-PN, marking a potential breakthrough with self-administered therapy.

Search

Search